Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

被引:1
|
作者
Dupuis, Josephine [1 ]
Tauber, Marie [2 ,3 ]
Mahe, Emmanuel [4 ]
Jachiet, Marie [5 ]
Soria, Angele [6 ]
Tetart, Florence [7 ]
Puzenat, Eve [8 ]
Pasteur, Justine [9 ]
Raison-Peyron, Nadia [10 ]
Giordano-Labadie, Francoise [11 ]
Droitcourt, Catherine [12 ]
Leleu, Camille [13 ]
Nosbaum, Audrey [3 ]
Aubert, Helene [14 ]
Moigne, Marie L. E. [14 ]
Bernier, Claire [14 ]
Barbarot, Sebastien [15 ]
Ezzedine, Khaled [16 ]
Diaz, Emmanuelle [16 ]
Hubiche, Thomas [17 ]
Faiz, Sarah [18 ]
Azib, Selma [1 ]
Dezoteux, Frederic [1 ,19 ]
Chosidow, Olivier [20 ]
Staumont-Salle, Delphine [1 ,19 ]
机构
[1] CHU Lille, Serv Dermatol, F-59037 Lille, France
[2] CHU Toulouse, Hop Larrey, Serv Dermatol, Toulouse, France
[3] Hop Lyon Sud, Allergol & Immunol Clin, CIRI Inserm U1111, Lyon, France
[4] Hop Victor Dupouy, Serv Dermatol, Argenteuil, France
[5] Hop St Louis, Dermatol, AP HP, Paris, France
[6] Hop Tenon, AP HP, Dermatol & Allergol, Paris, France
[7] CHU Rouen, Dermatol, Rouen, France
[8] CHU Besancon, Dermatol, Besancon, France
[9] CHU Clermont Ferrand, Dermatol, Clermont Ferrand, France
[10] CHU Montpellier, Dermatol, Montpellier, France
[11] CHU Toulouse, Dermatol, Toulouse, France
[12] Univ Rennes, Irset Inst Rech Sante, Dept Dermatol, CHU Rennes,Inserm,EHESP,UMR S 1085, Rennes, France
[13] Hop Bocage, Dermatol, Dijon, France
[14] CHU Nantes, Dermatol, Nantes, France
[15] Nantes Univ, Dept Dermatol, CHU Nantes, INRAE,UMR 1280,PhAN, Nantes, France
[16] Hop Henri Mondor, AP HP, Dermatol, Creteil, France
[17] Hop Archet 2, Dermatol, Nice, France
[18] CH Douai, Dermatol, Douai, France
[19] Univ Lille, Lille Inflammat Translat Res Inst INFINITE, INSERM U1286, Lille, France
[20] Univ Hosp La Pitie Salpetriere, AP HP, Facial Dermatosis Clin, Paris, France
关键词
D O I
10.1111/jdv.20264
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:e174 / e178
页数:5
相关论文
共 50 条
  • [31] Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
    Bronova, Irina
    Berdyshev, Evgeny
    Goleva, Elena
    Danby, Simon
    Bronoff, Anna Sofia
    Richers, Brittany
    Garcia, Shannon
    Gama, Marco Ramirez
    Taylor, Patricia
    Zahn, Joseph
    Agueusop, Inoncent
    Bafna, Shantanu
    Boguniewicz, Mark
    Ong, Peck
    Zhang, Annie
    Cork, Michael
    Leung, Donald
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
  • [32] Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
    Mele-Ninot, Gemma
    Curto-Barredo, Laia
    Bonfill-Orti, Montserrat
    Exposito-Serrano, Vicente
    Munera-Campos, Monica
    Figueras Nart, Ignasi
    Riquelme-Mc Loughlin, Constanza
    Gomez-Armayones, Sara
    Spertino, Jorge
    Serra-Baldrich, Esther
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (02) : 153 - 162
  • [33] Dupilumab in Combination With JAK Inhibitor for Refractory Moderate-to-Severe Atopic Dermatitis
    Song, Xiaoting
    Liu, Bo
    Peng, Chengyue
    Tan, Yen
    Zhao, Zuotao
    DERMATOLOGIC THERAPY, 2024, 2024 (01)
  • [34] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Andreas Kuznik
    Gaëlle Bégo-Le-Bagousse
    Laurent Eckert
    Abhijit Gadkari
    Eric Simpson
    Christopher N. Graham
    LaStella Miles
    Vera Mastey
    Puneet Mahajan
    Sean D. Sullivan
    Dermatology and Therapy, 2017, 7 : 493 - 505
  • [36] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Bronova, Irina
    Bronoff, Anna Sofia
    Richers, Brittany N.
    Garcia, Shannon
    Ramirez-Gama, Marco
    Taylor, Patricia
    Praestgaard, Amy
    Agueusop, Inoncent
    Jurvilliers, Pauline
    Boguniewicz, Mark
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    Leung, Donald Y. M.
    ALLERGY, 2022, 77 (11) : 3388 - 3397
  • [37] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Kuznik, Andreas
    Bego-Le-Bagousse, Gaelle
    Eckert, Laurent
    Gadkari, Abhijit
    Simpson, Eric
    Graham, Christopher N.
    Miles, LaStella
    Mastey, Vera
    Mahajan, Puneet
    Sullivan, Sean D.
    DERMATOLOGY AND THERAPY, 2017, 7 (04) : 493 - 505
  • [38] Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
    Agache, Ioana
    Song, Yang
    Posso, Margarita
    Alonso-Coello, Pablo
    Rocha, Claudio
    Sola, Ivan
    Beltran, Jessica
    Akdis, Cezmi
    Akdis, Mubeccel
    Brockow, Knut
    Chivato, Tomas
    del Giacco, Stefano
    Eiwegger, Thomas
    Eyerich, Kilian
    Gimenez-Arnau, Ana
    Gutermuth, Jan
    Guttman-Yassky, Emma
    Maurer, Marcus
    Ogg, Graham
    Ong, Peck Y.
    O'Mahony, Liam
    Schwarze, Jurgen
    Werfel, Thomas
    Canelo-Aybar, Carlos
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2021, 76 (01) : 45 - 58
  • [39] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan, I
    Rubini, Norma P. M.
    Pires, Mario C.
    Rossi, Ana B.
    Zhang, Annie
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Shumel, Brad
    Bego-Le Bagousse, Gaelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
  • [40] EFFICACY AND SAFETY OF DUPILUMAB IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Worrell, Richard
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Dubost-Brama, Ariane
    Bansal, Ashish
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 31 - 32